ES549255A0 - Procedimiento para la obtencion de halogeno-hidroxi-flavonas - Google Patents

Procedimiento para la obtencion de halogeno-hidroxi-flavonas

Info

Publication number
ES549255A0
ES549255A0 ES549255A ES549255A ES549255A0 ES 549255 A0 ES549255 A0 ES 549255A0 ES 549255 A ES549255 A ES 549255A ES 549255 A ES549255 A ES 549255A ES 549255 A0 ES549255 A0 ES 549255A0
Authority
ES
Spain
Prior art keywords
flavones
hydroxy
procedure
obtaining halogen
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549255A
Other languages
English (en)
Other versions
ES8708220A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES8708220A1 publication Critical patent/ES8708220A1/es
Publication of ES549255A0 publication Critical patent/ES549255A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
ES549255A 1984-11-26 1985-11-25 Procedimiento para la obtencion de halogeno-hidroxi-flavonas Expired ES8708220A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3443007 1984-11-26
DE19853505611 DE3505611A1 (de) 1984-11-26 1985-02-19 Halogen-hydroxy-flavone

Publications (2)

Publication Number Publication Date
ES8708220A1 ES8708220A1 (es) 1987-10-01
ES549255A0 true ES549255A0 (es) 1987-10-01

Family

ID=25826817

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549255A Expired ES8708220A1 (es) 1984-11-26 1985-11-25 Procedimiento para la obtencion de halogeno-hidroxi-flavonas

Country Status (7)

Country Link
US (2) US4713465A (es)
EP (1) EP0183169B1 (es)
JP (1) JPH0749427B2 (es)
AU (1) AU586649B2 (es)
DE (2) DE3505611A1 (es)
ES (1) ES8708220A1 (es)
HU (1) HU194856B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
DE4011187A1 (de) * 1990-04-06 1991-10-10 Hoechst Ag Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte
EP0674530B1 (en) * 1992-12-21 2004-09-01 Mallinckrodt Inc. Radiolabeled polyhydric phenol compounds
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
PL179170B1 (pl) * 1995-09-15 2000-07-31 Inst Lekow Nowe zwiazki,pochodne genisteiny PL PL PL PL
AUPQ008299A0 (en) * 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
DE10242045B4 (de) * 2002-09-11 2014-03-20 Valmet Automotive Oy Cabriolet-Fahrzeug
US7373991B2 (en) * 2005-07-18 2008-05-20 Schlumberger Technology Corporation Swellable elastomer-based apparatus, oilfield elements comprising same, and methods of using same in oilfield applications
US9120744B2 (en) * 2007-04-16 2015-09-01 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
DE102011080517A1 (de) 2011-08-05 2013-02-07 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Messaufnehmer zur Bestimmung einer eine Aktivität eines Ziel-Ions in einem Messmedium repräsentierenden Messgröße

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473114A (de) * 1963-08-28 1969-05-31 Merck Ag E Verfahren zur Herstellung von substituierten Flavanoiden
CH471113A (de) * 1965-01-29 1969-04-15 Merck Ag E Verfahren zur Herstellung von wasserlöslichen Flavanoidderivaten
DE1518015C3 (de) * 1965-04-23 1974-06-06 Merck Patent Gmbh, 6100 Darmstadt Substituierte Flavanderivate sowie Verfahren zu ihrer Herstellung
FR5443M (es) * 1966-04-26 1967-10-09
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
IT1134205B (it) * 1980-11-11 1986-08-13 Bonomelli Spa Processo per la produzione di derivati flavonici ad attivita' medicinale
EP0108986A1 (en) * 1982-11-02 1984-05-23 Hokuriku Pharmaceutical Co.,Ltd N-substituted flavone-8-carboxamides
FR2543550B1 (fr) * 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique

Also Published As

Publication number Publication date
ES8708220A1 (es) 1987-10-01
EP0183169A2 (de) 1986-06-04
US4788215A (en) 1988-11-29
US4713465A (en) 1987-12-15
DE3505611A1 (de) 1986-05-28
DE3570077D1 (en) 1989-06-15
EP0183169B1 (de) 1989-05-10
EP0183169A3 (en) 1987-04-22
JPS61130284A (ja) 1986-06-18
JPH0749427B2 (ja) 1995-05-31
AU4988885A (en) 1986-06-05
AU586649B2 (en) 1989-07-20
HU194856B (en) 1988-03-28
HUT40098A (en) 1986-11-28

Similar Documents

Publication Publication Date Title
ES555049A0 (es) Procedimiento para la obtencion de arilciclopropil-cetonas
ES539782A0 (es) Procedimiento para la obtencion de 5-amino-1-fenil-pirazolessustituidos
ES551225A0 (es) Procedimiento para la obtencion de poliesterpoliuretanos
ES544341A0 (es) Procedimiento para la obtencion de heteroariloxiacetamidas
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES557542A0 (es) Procedimiento para la obtencion de 5-amino-1-piridil-pirazoles
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
ES550219A0 (es) Procedimiento para la obtencion de aminopolieteres alcoxi- lados
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES552950A0 (es) Procedimiento para la obtencion de i-benzoil-3-aril-ureas
ES544534A0 (es) Procedimiento para la obtencion de tioeteres alifaticos
ES553569A0 (es) Procedimiento para la obtencion de carbamoilimidazoles
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES543387A0 (es) Procedimiento para la obtencion de pirazolin-5-onas susti- tuidas
ES544511A0 (es) Procedimiento para la obtencion de fenoxialquilaminopropano-les substituidos
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES546551A0 (es) Procedimiento para la obtencion de arisulfonilguanidinas sustituidas
ES554606A0 (es) Procedimiento para la obtencion de piridiletil-dihidropiridinas
ES552759A0 (es) Procedimiento para la obtencion de 2-alquil-pentanonas
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas
ES546559A0 (es) Procedimiento para la obtencion de amidinoazoles
ES555532A0 (es) Procedimiento para la obtencion de benzotiopiranonas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201